Popular Articles

UQ Research Finds A Mother's Mental Health Can Impact On Children
Teenagers whose mothers have mental health impairments are likely to suffer behavioural problems, UQ research has found. Buy arimidex to treat cancer.

Free Clinics Affected By Primary Care Physician Shortage
In the face of growing numbers of uninsured and low-income patients due to the economy, some free clinics are having difficulty meeting the increased demand, the Cleveland Plain Dealer reports. Since March, the Parma Health Ministry, in Cleveland, "which has only two volunteer primary care physicians who see patients in the evenings, has had to turn people away." Nicole Lamoureux, executive director of the National Association of Free Clinics, said the number of people seeking care at free clinics had increased by 40 to 50 percent in recent months, and that many of the newcomers have recently lost insurance coverage.

generic viagra online


News of the day
Ingelheim And The World Stroke Organization Announce Partnership In The World Stroke Academy
Boehringer Ingelheim announced today that it will become the founding sponsor of the World Stroke Academy, a novel training initiative for stroke professionals being developed by the World Stroke Organization (WSO). This latest educational initiative from the WSO will bring together an international group of stroke experts - led by Professor Michael Brainin of the Danube University Krems, Austria - to provide information about stroke and knowledge for health professionals and medical doctors in order to improve prevention, therapy and management of stroke.
Mental Health

Broad Therapy For Muscular Dystrophy

A group led by Dr. Paul T. Martin of The Ohio State University College of Medicine has demonstrated that the glycosyltransferase Galgt2 can lessen symptoms in multiple models of muscular dystrophy. Their report can be found in the July 2009 issue of the American Journal of Pathology. Muscular dystrophy is a group of inherited muscular disorders that are characterized by progressive skeletal muscle weakness, defects in muscle proteins, and the death of muscle cells and tissue. Recent studies have shown that a number of genes can prevent muscle damage, even though they do not fix the genetic defect that causes the disease. However, these surrogate gene therapies have had limited applicability across different forms of muscular dystrophy. High expression of the protein Galgt2, which alters the expression and properties of other proteins expressed in skeletal muscle, lessens the symptoms of muscular dystrophy in models with decreased expression of either dystrophin or laminin. Xu et al examined the effects of Galgt2 overexpression in a mouse model of limb girdle muscular dystrophy 2D. Galgt2 overexpression resulted in lower levels of muscle damage, and galgt2 gene therapy protected muscle fibers from injury. Increasing Galgt2 expression may therefore have therapeutic benefits in a broad range of muscular dystrophies. Dr. Martin and colleagues "have developed [a] gene therapy approach to overexpress the Galgt2 cDNA. ̣€¦Future work will entail developing methods to allow systemic delivery of such gene therapy vectors using the human Galgt2 cDNA driven by muscle- or muscle/heart-specific promoters. ̣€¦ [They also plan to] identif[y] drugs that would increase [Galgt2] expression in muscle ̣€¦ to stimulate the therapeutic effects of Galgt2 over-expression." Xu R, DeVries S, Camboni M, Martin PT: Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice. Am J Pathol 2009, 174: 2645-2657 Angela Colmone American Journal of Pathology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):